{"bill": {"@bill-stage": "Introduced-in-Senate", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Ethical Stem Cell Research Tax\n\t\t\t Credit Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as\n\t\t\t the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short\n\t\t\t title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Credit for\n\t\t\t ethical stem cell research"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is amended by adding at the end the following new\n\t\t\t section:", "@entity-type": "act", "#text": "Subpart D of part IV of subchapter A of chapter 1 of the\n\t\t\t Internal Revenue Code of 1986", "@value": "Internal Revenue Code of 1986/ch:1/sch:A/pt:IV/spt:D"}, "#text": "\n          "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "45S."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Ethical stem\n\t\t\t\tcell research"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", in the case of an eligible\n\t\t\t\ttaxpayer, the ethical stem cell research credit determined under this section\n\t\t\t\tfor the taxable year shall be an amount equal to 30 percent of the qualified\n\t\t\t\tstem cell research expenses paid or incurred by the taxpayer during the taxable\n\t\t\t\tyear.", "@entity-type": "act", "#text": "section 38", "@value": "Internal Revenue Code of 1986/s:38"}, "#text": "For purposes of "}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Allowance of\n\t\t\t\tcredit"}, "#text": "\n              ", "@id": "ID0126c3df4c9a4148806e1e8d9b0391a0"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means any taxpayer that elects the application of this section\n\t\t\t\tfor the taxable year.", "#text": "eligible\n\t\t\t\ttaxpayer"}, "#text": "For purposes of this section, the term "}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Eligible\n\t\t\t\ttaxpayer"}, "#text": "\n              ", "@id": "id994CD6936B514444B465D3C1C35B8FFE"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "For purposes of this section\u2014"}, "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n              ", "#text": "Qualified stem\n\t\t\t\tcell research expenses"}, "paragraph": [{"#tail": "\n              ", "@id": "ID1d3a6193df1549df989efa0e0f82bbf5", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means expenses which are paid or incurred by the eligible\n\t\t\t\ttaxpayer during the taxable year in carrying on basic and applied research to\n\t\t\t\tdevelop techniques for the isolation, derivation, production, testing, and\n\t\t\t\thuman clinical use of stem cells that may result in improved understanding of\n\t\t\t\tor treatments for diseases and other adverse health conditions, no part of\n\t\t\t\twhich may involve\u2014", "#text": "qualified stem cell research\n\t\t\t\texpenses"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the creation of a\n\t\t\t\thuman embryo for research purposes,"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "id164511D3D9B54980BE8958A8E2217201", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the destruction\n\t\t\t\tof or discarding of, or risk of injury to, a human embryo, or"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "id44E5A0F825AB43BE9E5D652F68C3FA08", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Internal Revenue Code of 1986/s:45S/ss:c/p:1/sp:A", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(B)", "@value": "Internal Revenue Code of 1986/s:45S/ss:c/p:1/sp:B", "@proposed": "true"}], "#text": "the use of any\n\t\t\t\tstem cell, the derivation or provision of which would be inconsistent with\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "id4C74C6469CB14AEA8BB4736E8442E82F", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means any organism not\n\t\t\t\tprotected as a human subject under part 46 of title 45, Code of Federal\n\t\t\t\tRegulations (as in effect on the date of the enactment of this section) that is\n\t\t\t\tderived by fertilization, parthenogenesis, cloning, or any other means from one\n\t\t\t\tor more human gametes or human diploid cells.", "#text": "human embryo"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Human\n\t\t\t\tembryo"}, "#text": "\n                ", "@id": "IDfb14a75bdcb44dd48d43f31f02ebabe0"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means subjecting a\n\t\t\t\thuman embryo to risk of injury or death greater than that allowed for research\n\t\t\t\ton a fetus in utero under ", "#text": "risk of injury"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " (as in effect on the date of the enactment of this section) and\n\t\t\t\tsection 46.204(b) of title 45, Code of Federal Regulations (as so in\n\t\t\t\teffect).", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 498(b) of the Public Health Service Act", "@value": "Public Health Service Act/s:498/ss:b"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42\n\t\t\t\tU.S.C. 289g(b)", "@value": "usc/42/289g/b"}], "@entity-type": "law-citation", "#text": "\n                    "}}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Risk of\n\t\t\t\tinjury"}, "#text": "\n                ", "@id": "IDbfe5a93f62144d5d84793fa80af02854"}], "#text": "\n              ", "@id": "ID8e2c82f881ea4e979e3e823999680bb4"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Treatment of\n\t\t\t\tqualified stem cell research expenses"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", any qualified stem\n\t\t\t\tcell research expenses for a taxable year to which an election under this\n\t\t\t\tsection applies shall not be taken into account for purposes of determining the\n\t\t\t\tcredit allowable under ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Internal Revenue Code of 1986/s:45S/ss:d/p:2", "@proposed": "true"}, {"#tail": " for such taxable year.", "@entity-type": "act", "#text": "section 41", "@value": "Internal Revenue Code of 1986/s:41"}], "#text": "Except as provided in "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "id0F398E5C579A4C1BA9F6C5B1732806C0"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ") shall be taken into account in determining base\n\t\t\t\tperiod research expenses for purposes of applying ", "@entity-type": "act", "#text": "section 41(b)", "@value": "Internal Revenue Code of 1986/s:41/ss:b"}, {"#tail": " to subsequent\n\t\t\t\ttaxable years.", "@entity-type": "act", "#text": "section 41", "@value": "Internal Revenue Code of 1986/s:41"}], "#text": "Any qualified stem cell research\n\t\t\t\texpenses for any taxable year which are qualified research expenses (within the\n\t\t\t\tmeaning of "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Treated as base\n\t\t\t\tperiod research expenses"}, "#text": "\n                ", "@id": "id5457B6C4955B4783B33B09625F96577D"}], "#text": "\n              ", "@id": "ID0931027ab9bc4371a67e23fa7878cdd4"}, {"#tail": "\n          ", "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Special\n\t\t\t\trules"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tapplies.", "@entity-type": "act", "#text": "section 936", "@value": "Internal Revenue Code of 1986/s:936"}, "#text": "No\n\t\t\t\tcredit shall be allowed under this section with respect to any stem cell\n\t\t\t\tresearch conducted by a corporation to which an election under "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Limitation"}, "#text": "\n                ", "@id": "idA6A996245EB74C4C9956A4C88EFDFE67"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "paragraphs (1) and (2) of section 41(f)", "@value": "Internal Revenue Code of 1986/s:41/ss:f/p:1, 2"}, {"#tail": " shall apply for\n\t\t\t\tpurposes of this\n\t\t\t\tsection.", "@entity-type": "act", "#text": "section 41(g)", "@value": "Internal Revenue Code of 1986/s:41/ss:g/p:1, 2"}], "#text": "Rules similar to the rules\n\t\t\t\tof "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Aggregation of\n\t\t\t\texpenditures and allocations of credit"}, "#text": "\n                ", "@id": "id8C4AB01AA668401F9059EDD4E60C5448"}], "#text": "\n              ", "@id": "id3BEF191A687C4E79964670A57F12944B"}], "#text": "\n            ", "@id": "ID719d1b938f8d4a999b0ea9350d35088f"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id8BC6D2ED98634406BDD79FEDCAC160FA"}, "#text": "\n        ", "@id": "id274280557C9849DAB436B095B036ECDF"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " is amended by striking ", "@entity-type": "act", "#text": "Section 38(b) of the Internal Revenue Code\n\t\t\t of 1986", "@value": "Internal Revenue Code of 1986/s:38/ss:b"}, {"#tail": ", by striking the period at the end of ", "@entity-type": "act", "#text": "paragraph\n\t\t\t (35)", "@value": "Internal Revenue Code of 1986/s:38/ss:b/p:35"}, {"#tail": " and inserting\n\t\t\t ", "@entity-type": "act", "#text": "paragraph (36)", "@value": "Internal Revenue Code of 1986/s:38/ss:b/p:36"}], "#text": "\n          ", "quote": [{"#tail": " at the end of ", "#text": "plus"}, {"#tail": ", and by adding at the end the following new\n\t\t\t paragraph:", "#text": ", plus"}]}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Credit allowed\n\t\t\t as part of general business credit"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t45S(a)", "@value": "Internal Revenue Code of 1986/s:45S/ss:a", "@proposed": "true"}, "#text": "the ethical stem\n\t\t\t\tcell research credit determined under "}, "enum": {"#tail": "\n            ", "#text": "(37)"}, "@id": "idD3B845F19366478AA3977887B97EB19D", "#text": "\n            "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "idB20646D77DC34C04A7D7AB4F7D0F44BE"}, "#text": "\n        ", "@id": "idA323398CDA5A43018644404A01C29FA5"}, {"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Denial of\n\t\t\t double benefit"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as added by ", "@entity-type": "act", "#text": "subsection (g) of section 280C of the\n\t\t\t Internal Revenue Code of 1986", "@value": "Internal Revenue Code of 1986/s:280C/ss:g"}, {"#tail": ", is redesignated as ", "@entity-type": "act", "#text": "section 1401(b) of the Patient\n\t\t\t Protection and Affordable Care Act", "@value": "Patient Protection and Affordable Care Act/s:1401/ss:b"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (i)", "@value": "Internal Revenue Code of 1986/s:280C/ss:i"}], "#text": "The second "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Technical\n\t\t\t amendment"}, "#text": "\n          ", "@id": "idC41CDB4C87D640E38A7823BBF26DD1FB"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as\n\t\t\t amended by ", "@entity-type": "act", "#text": "Section 280C of the Internal Revenue Code of 1986", "@value": "Internal Revenue Code of 1986/s:280C"}, {"#tail": ", is further amended by adding at the end the following\n\t\t\t new subsection:", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Ethical Stem Cell Research Tax Credit Act of 2013/s:2/ss:c/p:1", "@proposed": "true"}], "#text": "\n            "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "In\n\t\t\t general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "subsection": {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(j)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Ethical stem\n\t\t\t\tcell research credit"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ")\n\t\t\t\totherwise allowable as a deduction for the taxable year which is equal to the\n\t\t\t\tamount of the credit determined for such taxable year under ", "@entity-type": "act", "#text": "section 45S(c)(1)", "@value": "Internal Revenue Code of 1986/s:45S/ss:c/p:1", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t45S(a)", "@value": "Internal Revenue Code of 1986/s:45S/ss:a", "@proposed": "true"}], "#text": "No deduction shall be allowed for that portion of the\n\t\t\t\tqualified stem cell research expenses (as defined in "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "ID0a9dda9d1a8b4f5a8aa20a28f5107e03"}, {"continuation-text": {"#tail": "\n              ", "@continuation-text-level": "paragraph", "#text": "the amount\n\t\t\t\tchargeable to capital account for the taxable year for such expenses shall be\n\t\t\t\treduced by the amount of such excess."}, "#tail": "\n              ", "@id": "IDad93f5f579f54bf7ae16abf39394d863", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Similar rule\n\t\t\t\twhere taxpayer capitalizes rather than deducts\n\t\t\t\texpenses"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "If\u2014"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", exceeds", "@entity-type": "act", "#text": "section 45S(a)", "@value": "Internal Revenue Code of 1986/s:45S/ss:a", "@proposed": "true"}, "#text": "the amount of the\n\t\t\t\tcredit determined for the taxable year under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "ID5ebe7a9753a74a7d8ebdd1c341da7b60", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "),", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Internal Revenue Code of 1986/s:280C/ss:j/p:1", "@proposed": "true"}, "#text": "the amount\n\t\t\t\tallowable as a deduction for such taxable year for qualified stem cell research\n\t\t\t\texpenses (determined without regard to "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "IDc8744330994043df9d392a534f3699d9", "#text": "\n                  "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall apply for purposes\n\t\t\t\tof this\n\t\t\t\tsubsection.", "@entity-type": "act", "#text": "Paragraph (3) of subsection (b)", "@value": "Internal Revenue Code of 1986/s:280C/ss:b/p:3"}, "#text": "\n                  "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Controlled\n\t\t\t\tgroups"}, "#text": "\n                ", "@id": "ID98a8db84b16a410db4a25eae512e0228"}], "#text": "\n              ", "@id": "id4A5EDF1825754027B6687ACF7D730E4F"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "id31CEE631237B4786840F3C9BEBFE7C01"}, "#text": "\n          ", "@id": "idD0B89CE8BA8F40EC8B5E7281B58844C5"}], "#text": "\n        ", "@id": "idD4ECBB5A3F8B489ABB43FB6538AAE6C3"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is amended by\n\t\t\t adding at the end the following new item:", "@entity-type": "act", "#text": "subpart D of part IV of\n\t\t\t subchapter A of ", "external-xref": {"#tail": " of the Internal Revenue Code of 1986", "@parsable-cite": "usc-chapter/26/1", "#text": "chapter 1", "@legal-doc": "usc-chapter"}, "@value": "Internal Revenue Code of 1986/ch:1/sch:A/pt:IV/spt:D"}, "#text": "The table of sections for "}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Clerical\n\t\t\t amendment"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "@display-inline": "no-display-inline", "toc": {"#tail": "\n\t\t\t\t\t", "toc-entry": {"#tail": "\n\t\t\t\t\t", "#text": "Sec. 45S. Ethical stem cell\n\t\t\t\tresearch.", "@level": "section"}, "#text": "\n\t\t\t\t\t\t", "@regeneration": "no-regeneration"}, "#text": "\n\t\t\t\t\t", "@id": "id5F071610B7F740E9B7838ACAD7E0C233"}, "#text": "\n        ", "@id": "id7CB8D6C7B0744708BB0F9A45C29B9D33"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "The amendments made by this section shall apply to amounts\n\t\t\t paid or incurred after the date of the enactment of this Act."}, "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t Date"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idDE44CB7A478F4792B1CCD82F64F0BCFC", "@commented": "no"}], "#text": "\n      ", "@id": "idFE87EEFF70A34E108F2A98409D680BB1"}], "#text": "\n\t\t"}, "#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 136"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Internal Revenue Code of 1986 to provide a\n\t\t  Federal income tax credit for certain stem cell research\n\t\t  expenditures."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130124", "#text": "January 24\n\t\t\t (legislative day, January 3), 2013", "@legis-day": "20130103"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": " introduced\n\t\t\t the following bill; which was read twice and referred to the\n\t\t\t ", "#text": "Mr. Vitter", "@name-id": "S299"}, "committee-name": {"#tail": "\n      ", "@committee-id": "SSFI00", "#text": "Committee on\n\t\t\t Finance"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}}}